Patient dropouts before completion of optimal dose, multiple allergen immunotherapy

Annals of Allergy, Asthma and Immunology

Volumn 82, Issue 3, 1999, Pages 281-286

  Rhodes, Barry Joseph ^a,b  

^a MAYO CLINIC   (United States)

^b Midelfort Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ADULT; ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC REACTION; ANXIETY NEUROSIS; ARTICLE; DEMOGRAPHY; DEPRESSION; FEMALE; HEALTH INSURANCE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALADJUSTMENT; MALE; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL;

EID: 0033034816     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62609-9     Document Type: Article

References (20)

1. Tinkelman D, Smith F, Cole WQ, Silk HJ. Compliance with an allergen immunotherapy regime. Ann Allergy Asthma Immunol 1995;74:241-246.
2. Creticos PS. Immunotherapy with allergens. JAMA: Primer on allergic and immunologic disease. 1992;268(20): 2834-2839.
3. Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734-737.
4. Lower T, Henry J, Mandik L, et al. Compliance with allergen immunotherapy. Ann Allergy 1993;70:480-482.
5. Lin MS, Tanner E, Lynn J, Friday GA. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993;71: 557-562.
6. Van Metre TE Jr, Adkinson N Jr. Immunotherapy for aeroallergen disease. In: Middleton E Jr, Reed CE, Ellis EF, et al. Allergy principles and practice, 4th ed. St. Louis: Mosby, 1993;1489-1509.
7. Condemi JJ, Dykewitz MS, eds. Allergic immunotherapy. In: Medical knowledge self-assessment program: allergy and immunology, 2nd ed. Am Coll Phys USA 1997:92-97.
8. Bush RK, Huftel M, Busse W. Selection of patients (for immunotherapy). In: Lockey RF, Bukantz SC, eds. Allergen immunotherapy. New York: Marcel Decker, 1991:25-50.
9. Bousquet J, Michel FB. In vivo methods for study of allergy: skin tests, techniques and interpretation. In: Middleton E Jr, Reed CE, Ellis E, et al. Allergy principles and practice, 4th Ed. St. Louis: Mosby, 1993:573-594.
10. Stewart GE, Lockey RF. Systemic reactions from allergen immunotherapy [Editorial]. J Allergy Clin Immunol 1992;90(4,part1):567-578.
11. Norman PS, Van Metre TE. The safety of allergen immunotherapy. J Allergy Clin Immunol 1990:Vol85(2):522-525.
12. American Academy Of Allergy And Clinical Immunology Board Of Directors. Position Statement: Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts. J Allergy Clin Immunol 1994;93:811-812.
13. Lockey R, Benedict LM, Turkeltaub P, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987;79(4):660-677.
14. Reid MJ, Lockey RF, Turkeltaub P, Platts-Mills TAE. Survey of fatalities from skin testing and immunotherapy 1985-89. J Allergy Clin Immunol 1993;92(1):6-15.
15. Hepner MJ, Ownby DR, Anderson JA, et al. Risk of systemic reactions in patients taking beta-blocker drugs receiving allergy immunotherapy injections. J Allergy Clin Immunol 1990; 86(3,Part1):407-411.
16. Haugaard L, Dahl R, Jacobsen L. A controlled dose-response study of immunotherapy with standardized, partially-purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993;91(3): 709-722.
17. Alvarez-Cuesta E, Cuesta-Herranz JV, Puyana-Ruiz J, et al. Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study. J Allergy and Clin Immunol 1994;93(3): 556-566.
18. Van Metre TE Jr, Marsh DG, Adkinson NF Jr, et al. Immunotherapy for cat asthma. J Allergy Clin Immunol 1988;82:1055-1068.
19. Greenberg MA, Kaufman CR, Gonzalez G, et al. Late systemic allergic reactions to inhalant allergen immunotherapy. J Allergy Clin Immunol 1988; 82:287-290.
20. Wynn S. Immunotherapy Compliance - A Shot In The Dark? [Editorial] Ann Allergy Asthma Immunol 1995;74: 195-197.